DNA Sequencing Patent Survives Guardant PTAB Challenge
The Patent Trial and Appeal Board has ruled that Guardant Health failed to show that challenged claims in a University of Washington patent for DNA sequencing were unpatentable, ahead of an...To view the full article, register now.
Already a subscriber? Click here to view full article